by Ellie Kroeger | May 27, 2026
Humans have been obsessed with eternal youth for thousands of years. The search for elixirs, tonics, and the philosopher’s stone can be traced back to ancient civilizations. Only in the 1990s, however, did research show that lifespan may be modifiable. Pathways such...
by Krystal Jacques | Apr 28, 2026
Spontaneous neuronal regrowth and repair are not observed in adult spinal cords, making paralysis from spinal cord injury devastating and often permanent. In a new study, Professor Samuel Stupp’s research team at Northwestern University created human spinal cord...
by Lyla El-Fayomi | Mar 12, 2026
Somehow we are already into March, and spring – at least in some places – feels close by. To catch you up, I’ve put together a recap of some of the research that scientists were buzzing about in the field of regenerative medicine from 2025; I cover the good, the bad,...
by Laya Kiani | Feb 12, 2026
In 2025, cell and gene therapy (CGT) showed growing clinical familiarity even as access and reimbursement challenges persisted. Providers and payers increasingly trusted and valued CGTs, supporting the continued expansion of late-stage programs. However, startup...
by Cal Strode | Jan 28, 2026
This year marks the fourth consecutive time I’ve covered the Alliance for Regenerative Medicine’s (ARM) State of the Industry briefing for Signals, and I’ve enjoyed tracking how the cell and gene therapy sector has evolved in real time. In 2023 and 2024, the briefings...
by Krystal Jacques | Jan 19, 2026
Hunter syndrome is one of the mucopolysaccharidoses, a group of lysosomal storage disorders caused by specific genetic mutations and missing enzymes. In Hunter syndrome, mutations in the X-linked iduronate-2-sulfatase (IDS) lead to deficiencies in the IDS enzyme,...
Comments